{"id":4177,"date":"2024-01-16T17:00:52","date_gmt":"2024-01-16T22:00:52","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/"},"modified":"2026-09-24T00:05:52","modified_gmt":"2026-09-24T04:05:52","slug":"laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/","title":{"rendered":"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Paris, France, le 16 janvier 2024, 18h00 CET <\/strong>\u2013 Le Conseil d\u2019administration GenSight Biologics (Euronext : SIGHT, ISIN\u00a0:\u00a0FR0013183985, \u00e9ligible PEA-PME) (la \u00ab\u00a0<strong>Soci\u00e9t\u00e9<\/strong>\u00ab\u00a0), soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement et la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives r\u00e9tiniennes et les troubles du syst\u00e8me nerveux central, a pris acte de la d\u00e9mission de Bernard Gilly de son mandat d\u2019administrateur. Le Conseil d\u2019administration annonce \u00e9galement aujourd\u2019hui sa d\u00e9cision, apr\u00e8s consultation du Comit\u00e9 des Nominations, de coopter Laurence Rodriguez en qualit\u00e9 d\u2019administrateur pour la dur\u00e9e du mandat restant \u00e0 courir de Bernard Gilly (soit jusqu\u2019\u00e0 l\u2019issue de l\u2019assembl\u00e9e g\u00e9n\u00e9rale ordinaire qui sera appel\u00e9e \u00e0 statuer en 2024 sur les comptes de l\u2019exercice clos le 31 d\u00e9cembre 2023).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La cooptation de Laurence Rodriguez sera soumise \u00e0 ratification lors de la prochaine assembl\u00e9e g\u00e9n\u00e9rale de la Soci\u00e9t\u00e9.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La nomination de Laurence Rodriguez en tant que directrice g\u00e9n\u00e9rale de la Soci\u00e9t\u00e9 a pris effet le 21\u00a0d\u00e9cembre 2023. Elle poss\u00e8de plus de 30 ans d\u2019exp\u00e9rience dans le secteur des sciences de la vie, dont 13 ans dans le secteur des maladies rares chez Sanofi Genzyme, o\u00f9 elle a occup\u00e9 diverses fonctions ex\u00e9cutives. En tant que Directrice de l\u2019entit\u00e9 \u00ab Maladies rares et maladies h\u00e9matologiques rares\u00a0\u00bb chez Sanofi Genzyme, elle a supervis\u00e9 le lancement r\u00e9ussi de nombreux traitements, d\u00e9velopp\u00e9s en interne ou r\u00e9sultant d\u2019acquisitions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Elle a rejoint GenSight Biologics en mai 2021, en tant que Directrice des Op\u00e9rations pour la France. Elle a ainsi g\u00e9r\u00e9 le programme d\u2019acc\u00e8s pr\u00e9coce en vue de la commercialisation de LUMEVOQ<sup>\u00ae<\/sup> et cr\u00e9\u00e9 des relations solides avec les parties prenantes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le conseil d&rsquo;administration tient \u00e0 remercier Bernard Gilly, co-fondateur de la Soci\u00e9t\u00e9 en 2012 aux c\u00f4t\u00e9s du Pr. Jos\u00e9-Alain Sahel, pour ses nombreuses ann\u00e9es de d\u00e9vouement au sein de la Soci\u00e9t\u00e9, et sa contribution essentielle pour faire de LUMEVOQ<sup>\u00ae<\/sup> une th\u00e9rapie capable de transformer la vie des patients.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le Conseil d\u2019administration est compos\u00e9 de 8 membres, dont 5 administrateurs ind\u00e9pendants et un censeur.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Conseil d\u2019administration de GenSight Biologics annonce ce jour la cooptation de Laurence Rodriguez en tant qu\u2019administrateur et prend acte de la d\u00e9mission de Bernard Gilly<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[79],"news-type":[76],"post-year":[],"class_list":["post-4177","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-topic-company-and-personnel","news-type-corporate"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Le Conseil d\u2019administration de GenSight Biologics annonce ce jour la cooptation de Laurence Rodriguez en tant qu\u2019administrateur et prend acte de la d\u00e9mission de Bernard Gilly\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-16T22:00:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:52+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9\",\"datePublished\":\"2024-01-16T22:00:52+00:00\",\"dateModified\":\"2026-09-24T04:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/\"},\"wordCount\":391,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/\",\"name\":\"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2024-01-16T22:00:52+00:00\",\"dateModified\":\"2026-09-24T04:05:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/01\\\/16\\\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/","og_locale":"fr_FR","og_type":"article","og_title":"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9 - GenSight Biologics","og_description":"Le Conseil d\u2019administration de GenSight Biologics annonce ce jour la cooptation de Laurence Rodriguez en tant qu\u2019administrateur et prend acte de la d\u00e9mission de Bernard Gilly","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/","og_site_name":"GenSight Biologics","article_published_time":"2024-01-16T22:00:52+00:00","article_modified_time":"2026-09-24T04:05:52+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9","datePublished":"2024-01-16T22:00:52+00:00","dateModified":"2026-09-24T04:05:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/"},"wordCount":391,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/","name":"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2024-01-16T22:00:52+00:00","dateModified":"2026-09-24T04:05:52+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/01\/16\/laurence-rodriguez-nommee-directrice-generale-de-gensight-biologics-en-decembre-2023-rejoint-le-conseil-dadministration-de-la-societe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Laurence Rodriguez, nomm\u00e9e directrice g\u00e9n\u00e9rale de GenSight Biologics en d\u00e9cembre 2023, rejoint le conseil d\u2019administration de la Soci\u00e9t\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4177"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4177\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4177"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4177"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4177"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4177"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}